Member Info for granth81

Could be a great afternoon here. We know how fast this moves. Just exhausting the last of the weak hands as we speak

We now need offtakes and funding, flat day today or red but will eventually work its way to the 30p to 40p range

Looking good this morning. Beehive news due imminently

#BRES near term catalysts 🔥

1 - Maiden Iyan JORC Resource Estimate (Imminent – this week

2 - Beehive Deposit Resource Update / Assays (Follow-on from Iyan, expected very near term

3 - Progress on P1 Funding / Offtake Announcements March / April

4 - Final US ITC Determination on Chinese Graphite AD/CVD Duties (Expected March 2026)

5 - Broader Technical / Downstream Validation (Ongoing H1 2026)

6 - Institutional / Strategic Interest / Takeover Speculation (Triggered by above)

Iyan JORC first (imminent catalyst), then Beehive/funding combo for legs higher, with US duties as macro kicker this month. Setup’s strong – warrant overhang gone, MMs thin, momentum building.

It’s been a massive week for #BRES but the Maiden Iyan JORC resource estimate is probably dropping this Monday! If that’s the case, buckle up because this could be the proper spark we’ve all been waiting for.

Could gap us toward 15-18p quick if numbers exceed (as assays suggest), then legs higher on follow-through. Im calling for 20p+ short-term on this alone, with Beehive next adding fuel.

If Monday’s the day, this is the catalyst that closes the discount and wakes ii’s/strategics properly. Retail’s been driving the run – now the real money follows.

Hey lads, quick update on BRES valuation now that we’re flying – closed at a fresh high of 10.50p yesterday (25 Feb 2026, up over 6% on massive volume ~6.6m+ shares), mcap ~£57m, and the setup’s looking even stronger for why a realistic takeover or re-rate target sits around 35p right now, but once those new JORC upgrades drop on both Iyan and Beehive in the coming weeks/months (maiden Iyan imminent Q1, Beehive likely following), we’re easily talking 50p+ territory.

Right now at 10.5p, the market’s pricing in the existing DFS numbers: that monster US$1.087bn post-tax NPV10 (~£800m+), 96% IRR, low costs, staged capex, premium product (99.99% purified + synthetic diamond feedstock play), offtakes building, US China graphite duties locked in favoring non-China assets like this in stable Uganda.

Broker like Oak had it at 33.7p back in Jan using peer multiples on the current resource – and that’s before any expansion credit. With LTIP tying management to P1 funding (or change of control vesting), funding talks active (DFIs/strategics/institutions), and no warrant overhang left, 35p feels like fair value today if a bid lands or funding news hits – that’s roughly a 230% premium but still only ~15-20% of NPV discounted for remaining risks. Peers in graphite/development get taken out in that ballpark when de-risked and strategic interest spikes.

But the real kicker’s coming: Iyan maiden JORC is “imminent” / before end Q1 per the final assays released 24 Feb – those last batches smashed expectations again with thick near-surface high-grade intercepts (multiple 30m+ zones), reinforcing bulk blending, low strip, and massive resource growth. Current Orom-Cross JORC is ~26Mt (only main deposits), zero from Iyan or Beehive yet. Adding Iyan alone could beef it up significantly (management’s been teasing “materially increase overall resource base”), extending mine life, scaling production, improving economics further.

Then Beehive follows – another new zone with similar potential.

Once both upgrades land (H1 2026 likely for full impact), that NPV jumps higher (more tonnes = more cash flow, longer life, better blending for premium products), de-risks funding/offtake even more, and attracts bigger strategic eyes avoiding China supply. In juniors, a chunky resource upgrade often doubles/triples valuation overnight – think 50-100%+ pops on news. From here, pushing toward 50p+ (mcap £270m+, still <30% of bumped-up NPV) doesn’t look stretchy at all – aligns with full de-risked graphite asset comps and the macro screaming for secure supply.

Chart’s supportive: new highs, blue sky technically, momentum strong. Retail’s driving it, but ii’s will pile in post-upgrade, and takeover chatter ramps (LTIP bait obvious). Holding tight – feels like 35p is the floor now, 50p+ the next leg once JORCs confirm the scale.

How can such an asset be worth so little?

Price has been driven down on purpose.

I do how ever see a buyout at 1.5p to 1.8p

Blencowe Resources Plc has announced the final assay results from 87 shallow holes drilled at the Iyan deposit, part of its Orom-Cross Graphite Project in Uganda, which reinforce its bulk blending strategy and support an imminent maiden JORC resource estimate. The results confirm thick, continuous near-surface graphite mineralization, with multiple intercepts exceeding 30 meters from surface and several holes ending in mineralization, indicating potential for deeper continuation. These findings are expected to increase the overall Orom-Cross resource base and support ongoing funding and offtake discussions, with the maiden Iyan JORC resource estimate anticipated in Q1 2026.

I’m convinced the ii window opens imminently – probably triggered by the next RNS on funding/offtake/assays. Loading dips while retail still leads, but the smart money follows soon.

Feels like we’re right at that tipping point now. Here’s why I reckon the ii buying wave kicks off very soon – potentially next few weeks to months, especially if we hold above 9-10p today

First off, the project’s de-risked: DFS done ages ago, recent Iyan drilling still delivering thick high-grade intercepts from surface (those Feb assays reinforcing resource growth and bulk blending for production), purification to 99.99% confirmed, plus the synthetic diamond feedstock angle opening premium non-battery markets. Offtakes building (TaiDa etc., more MOUs/LOIs like Alkeemia in Jan for European processing), and macro tailwinds huge with US AD/CVD duties on Chinese graphite hitting ~160% – final ITC call expected March, which locks in support for non-China plays like Orom-Cross.

Funding talks are humming: company keeps saying discussions active with DFIs, strategics, institutions, and gov bodies for non-dilutive P1 phase 1 cash. Then bam – last week (20 Feb) they drop the 30m LTIP shares to management/directors (6.3% of cap), half vesting straight on securing that P1 funding (or change of control). That’s massive alignment – management’s basically betting their upside on nailing funding soon. In juniors, when the board ties big personal rewards to a milestone like this, it often signals they’re close and want to motivate the team hard. Change of control vest immediate? Classic takeover bait too.

Warrant overhang’s history after those Jan/Feb exercises dried up – no more dumping pressure. MMs look thin, bids firm, and today’s volume spike without sellers crushing it screams accumulation. Retail’s been driving the move from sub-3p to here, but at ~£50m+ mcap now (pushing £53m ish at 9.7p), it’s hitting the sweet spot where ii’s start sniffing: low enough to build meaningful stakes without spiking the price too much, but de-risked enough with catalysts stacking.

Once funding progress (P1 news, term sheet, or even partial commitment) or resource upgrade lands – or March US duties finalised boosting sentiment – expect the first TR-1s to pop. Institutions hate missing out on these graphite stories with China risks and EV/renewables demand exploding. We’ve seen it in peers: retail runs it up, then ii’s pile in for the leg to 20p+.

Chart’s supportive too – breaking highs, blue sky ahead technically. If we close above 10p today / tomorrow, that’s the signal for bigger money to wake up.

Strong start and a will start attacking 10p today / tomorrow

Not AIM - small cap main market rather.

Lads, strap in. At 9p today (~£45-49m mcap), Blencowe Resources is criminally undervalued vs. the monster catalysts lining up over the next 12 months. We’re talking DFS-validated beast, geopolitical rocket fuel, resource explosions, funding/offtake fireworks, and very real buyout potential. 10x (90p+) by Feb 2027 isn’t fantasy – it’s the base case if even half this stack hits. Here’s the blow-by-blow:

1. Tiny mcap vs. DFS NPV insanity – $1.1Bn NPV10, 96% IRR, Phase 1 low-capex (~$40m) targeting first production 1H 2027 with ~$230m avg annual EBITDA. Peers in graphite/development trade at 20-50%+ of NPV even pre-funding. At current mcap we’re pricing in <5% of that NPV. One rerate to 20-30% NPV (standard for funded juniors) = 5-10x easy. Add resource growth and we’re laughing.

2. Resource upgrades incoming – massive scale unlocked – Only ~2% of the license drilled so far. Recent Iyan/Beehive assays are crackers: multiple 30m+ @7-11% TGC from surface, +90m intercepts at 6-7%. More assays flowing progressively, building to updated JORC Resources/Reserves in coming months (Q1/Q2 2026). Broker (Oak Jan ’26) flagged potential to double+ the current resource post-drilling. Bigger resource = bigger mine life, lower risk, higher valuation multiples. This alone could 3-5x us as numbers land.

3. US tariffs = perfect storm for non-China supply – Feb ‘26 US DoC slapped ~160% AD/CVD on Chinese graphite AAM. Final ITC affirmative expected March. This is game-changing – Western battery/EV players desperate for secure, ex-China feedstock. Blencowe’s premium Uganda graphite + downstream plans (SPG, even synthetic diamond feedstock confirmed Feb ‘26) positions it as a top Western alternative. DFC $5M grant already in, Mike’s Washington visits – funding momentum building hard.

4. Funding & offtakes de-risking fast – Targeting P1 finance close end-Q1/early Q2 2026 (tier-1 likely, DFC heavy). Offtakes/MOUs already with Yunasko, Alkeemia, TaiDa etc. – more coming. Recent LTIP (20 Feb ’26): 30m shares (6.3% of cap) to directors, vesting half on P1 funding secured, immediate full vest on change of control. Skin in the game + clear alignment for big exit or funded path. Funding news = massive rerate.

5. Buyout premium the wildcard moonshot – As per M&A takes on the board, 60%+ chance of strategic buyout once funding de-risks (battery giant, processor, sovereign fund). Why risk execution when you can snap up a DFS-done, tariff-proof asset at discount? Premiums in this space 100-300%+ common. Even conservative 50-100% premium on current = 13.5-18p quick, but with catalysts stacking, approach could see 40-90p+ bids. Full funding self-build? Still 5-10x+ longer-term as production ramps.

Risks? Yes – funding slips, graphite price wobbles, execution. But downside protected at this mcap (cash position ok, low burn), upside asymmetric as hell. We’ve seen AIM graphite juniors explode 10x+ on less (think 2021-22 runs). Current price action: up from 2.55p low,

Solid post, mate – appreciate the M&A perspective, especially from someone who’s seen how these deals get structured in practice. You’re spot on that a tier-one funder (DFC vibes strong here) is the realistic path, and anything smaller would be a massive red flag. Mike’s DC trip late last year (and the ongoing chatter around it) plus the fresh $5M DFC grant already locked in screams they’re playing in the big leagues for that non-dilutive / strategic debt piece.

The LTIP announcement yesterday (20 Feb) is telling – 30m shares (6.3% of cap) vesting half on P1 funding secured, and full immediate vest on change of control. That’s classic alignment for either a funded development path or a full/partial exit. Management’s clearly incentivised to deliver a big outcome, not just limp along.

Your 40/60 split (full funding vs buyout) feels about right to me too, maybe even tilting more towards buyout given the geopolitics. With US AD/CVD ~160% on Chinese AAM now locked (Feb ruling), final ITC in March, and everyone scrambling for ex-China, secure, high-quality graphite feedstock – a strategic (think battery giant, downstream processor, or even sovereign fund) swooping in to take the whole thing or a controlling stake makes tons of sense. Why risk execution on P1/P2 when you can buy the DFS-validated asset outright at a discount to that $1.1Bn NPV?

Current setup: tiny ~£43m mcap at 9p, post-DFS beast with low Phase 1 capex (~$40m), offtakes/MOUs building (Yunasko, Alkeemia etc.), resource exploding (Iyan/Beehive high-grade from surface, more assays/JORC upgrade imminent), and funding targeted end-Q1. If no buyout, a funded P1 still rerates us hard; if buyout, premium inevitable.

I’m loaded up and happy either way – buyout would be nice quick multiple (I’d guess 20-40p+ territory realistic on approach), self-build longer but moonshot potential. Conviction remains sky-high.

What premium do you think a buyer would pay in a buyout scenario here? Or any names you’ve heard floated in M&A circles for graphite plays like this?

GLA, and thanks for the insider-ish take – always good to hear from the coalface.

Small cap rather not aim

I’ve been deep in the BRES rabbit hole and honestly, this is shaping up to be one of the standout AIM stories for the year. Orom-Cross graphite project in Uganda is a Tier-1 beast, 100% owned, low-cost, long-life, and perfectly positioned for the EV/battery boom + non-China supply push.

Key reasons it’s the top small-cap prospect

1. DFS already out and it’s a stonker – December 2025 DFS confirmed world-class economics: US$1.1Bn NPV10, 96% IRR, low capex for Phase 1 (targeting first production 1H 2027 at 20ktpa concentrate + micronised). Average EBITDA ~US$230m pa over LOM. That’s insane margins for a graphite play. Phase 1 de-risks everything, then scales up massively.

2. JORC upgrades already delivered – more coming imminently – Nov 2025 major upgrade: Reserves up 47% to 23Mt @5.18% TGC, Resources 26Mt @5.58% from just ~2% of the license area drilled! That’s huge validation. But the real fireworks: further JORC update expected in Q1 2026 (we’re right in that window now) incorporating 192 step-out holes from new deposits like Iyan and Beehive.

3. Assays flowing in hot – high-grade near-surface intercepts everywhere – Recent Iyan results (Feb 2026): multiple 30m+ intercepts from surface, e.g. 31m @6.84% TGC incl. 12m @10.89%, another 30m @7.55% incl. 5m @11.74%. Beehive also delivered crackers like 92m @6.83% TGC from surface (Dec 2025). These are bulk-tonnage + higher-grade zones perfect for blending/low-cost production. Assays pending from more holes – expect steady news flow building to that big JORC upgrade.

4. Geopolitical tailwinds massive – US AD/CVD duties ~160% on Chinese graphite AAM just hit (Feb 2026 news), final ITC decision March. This screams need for ex-China supply. Blencowe’s premium East African graphite + downstream plans (SPG in Uganda) + US DFC $5M grant already in pocket positions it perfectly as a Western-friendly, secure source.

5. Funding/offtake momentum – Targeting P1 finance by end Q1 2026 to order/ship/construction through year, production 2027. Offtakes signed for P1, more negotiations underway. LTIP granted to directors tied to P1 funding vesting – skin in the game. Broker initiation (Oak Jan 2026) highlighted potential to double resource post-drilling.

Only ~2% of the tenement drilled – potential for billions of tonnes ultimate resource. Low strip ratio, shallow open-pit, high recoveries, premium product quality.

Current mcap tiny vs. peers, DFS numbers scream multi-bagger potential once funding locked and JORC/resources expand. Risks always there (funding, execution, graphite market), but catalysts are lining up thick and fast in 2026.

DYOR, but for me this is the one to load up on before the rerate

why are you using that shower of **** for?

They are selling coal out of the back door. This is a scam company that used pi’s money to fund the mine and then sell off cheap to the Chinese.

I’m not sure why anyone is still holding this.

Share price doing well for a few days…. So time for a massive placing….. you could see it a mile off.

It won’t be long before consistent 5-10% blue days as we rerate. We are closing in on funding now and getting to 25-35p should pretty much be nailed on.

15-20p is on the cards today